IndraLab
Statements
reach
"As shown in Fig. 4q, KRAS mutants significantly upregulated JOSD2 levels, but failed to pose similar effects in CHIP-depleted cells, indicating that KRAS mutants upregulated JOSD2 relying on CHIP.Given that JOSD2 functions as a DUB, we further investigate whether JOSD2 exhibits auto-DUB activity."
reach
"However, despite the activated state of YAP/TAZ, depletion of JOSD2 still shows more robust anti-tumor effects in KRAS-mutant xenografts compared to the wild-type counterparts, further demonstrating that the growth-inhibitory effect of JOSD2 knockdown depends, at least partially, on the degradation of mutant KRAS.Given that KRAS mutants upregulated JOSD2 levels relying on CHIP, whether CHIP overexpression plays a similar role as JOSD2 shRNA?"